Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
Clinical trial NCT04097301 · TERMINATED
Trial details
- NCT number
- NCT04097301
- Sponsor
- AGC Biologics S.p.A.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-27
- Primary completion
- 2021-06-18
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.